Navigation Links
Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Date:10/16/2009

achievements expressed or implied by such statements. There can be no guarantee that NPC or its affiliates will be successful in any other pricing litigation against it. In particular, management's expectations could be affected by, among other things, the inherent unpredictability of the litigation process, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, GI and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE: NVS), which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on growth areas in healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, and consumer health products. Novartis is the only company with leading positions in these areas. In 2
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... offering of 5,250,000 shares of its common stock at ... The net proceeds to Tandem from this offering are ... and commissions and other estimated offering expenses payable by ...
(Date:2/26/2015)... 2015  Today the National Safety Council ... physical side effects of pain medications , ... Vicodin and Oxycontin, are safer options than over-the-counter pain ... painkillers than on heroin and cocaine combined," said ... "Yet, these medications are marketed as the Cadillac option ...
(Date:2/26/2015)... SOUTH BEND, Ind. , Feb. 26, 2015 /PRNewswire/ ... to announce an agreement with Bank of America (NYSE: ... for consumers nationwide to receive financing of the revolutionary ... accessible vehicle, designed from the ground up to provide ... users. Approved applicants can use their loan to purchase ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... Grove, MN, announced today that the results of the ... of its NeuroFlo™ catheter – were presented on Saturday, ... at the 2010 World Stroke Congress in Seoul, South ... randomized trial of an acute interventional treatment in ischemic ...
... WASHINGTON, Pa., Oct. 18 McNeil Consumer Healthcare, Division ... TYLENOL® 8 Hour caplets 50 count bottles to the ... small number of complaints of a musty or moldy ... by the presence of trace amounts of a chemical ...
Cached Medicine Technology:CoAxia Announces Results of SENTIS Ischemic Stroke Trial 2CoAxia Announces Results of SENTIS Ischemic Stroke Trial 3McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in the United States and Puerto Rico 2
(Date:2/28/2015)... February 28, 2015 “ Powermod ” was ... which takes a look at the latest and coolest technology ... reporter for NewsWatch and a technology expert, conducted the review ... of charging solutions. , Getting stuck with a low battery ... a problem that people face on a daily basis. Even ...
(Date:2/28/2015)... 28, 2015 My Shiney Hiney® LLC., the ... team to Las Vegas, Nevada for the annual ASD Market ... of the leading consumer-goods tradeshows and My Shiney Hiney will ... event. My Shiney Hiney can be found at booth number ... for the at-home personal hygiene brush and cleansing system exclusively ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 ... Devices (IPD), has introduced miniature, wire bondable, silicon ESD ... Power LED markets. The ESD88NP and ... currents away from sensitive LED and IC products. ... Multilayer Varistors (MLV). All devices meet the requirements ...
(Date:2/27/2015)... February 27, 2015 Today, February 27th, is ... Brothers , along with LXR Organics and ... IT Campaign to raise awareness and promote prevention, rescue and ... provided by the END IT Coalition, slavery is the 2nd ... and exists in 167 countries around the world. Slavery includes ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Altec Products, ... as their Sage ERP Document Management Partner of the ... ERP, Sage CRM and other complimentary solutions for their ... worked side-by-side for many years to provide clients with ... applications. , “We are thrilled to recognize ADSS ...
Breaking Medicine News(10 mins):Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2
... ... by the 1998 Nobel Prize winner in Medicine is a boon for anyone who wants ... ... Dr. Mercola of Mercola.com released yesterday a new heart health product that also ...
... activity per week, experts say , FRIDAY, April 2 ... States do not get the recommended amount of exercise, ... 150 minutes of moderate-intensity aerobic activity per week, according ... Moderate-intensity exercise causes light sweating or a slight to ...
... Children,s Hospital Boston,s Pain Treatment Service has been named a ... honor that is bestowed upon five pain centers each year. ... nomination process. "We are honored to be named a ... Charles Berde, MD, PhD, chief of the pain management department ...
... Most deaths occurred when babies slept somewhere other than a ... are 12 times more likely to die from sleep-related causes ... shows. , Overall in the state of Illinois, where the ... to die from sleep-related causes. , Researchers in the Child ...
... ... vaccination rates, , ... Washington, DC (Vocus) April 2, 2010 -- The American Pharmacists Association (APhA) applauds the ... efforts to administer more than 90 million doses during the 2009-2010 influenza season. ...
... vice president of Emergency Medicine Clinical Operations at Thomas ... Department Director of the Year by the Emergency Medicine ... receive his award at the American College of Emergency ... "I am extremely honored to be recognized in such ...
Cached Medicine News:Health News:New Heart Health Booster Supports Blood Pressure in the Normal Range* 2Health News:New Heart Health Booster Supports Blood Pressure in the Normal Range* 3Health News:Only 1 in 4 Pregnant Women Gets Enough Exercise 2Health News:Sleep-Related Death Rate Higher Among Black Infants 2Health News:Pharmacists Play a Vital Role in Providing Immunizations in Their Communities, 2Health News:Pharmacists Play a Vital Role in Providing Immunizations in Their Communities, 3Health News:Jefferson physician named 2010 Emergency Department Director of the Year 2
Features soft, low friction sheath that extends beyond the tip....
Designed to retain the desired curve during oral intubation....
Facilitates intubation of tracheal tubes....
Facilitates intubation of tracheal tubes....
Medicine Products: